Business

Latest News

syringe biosimilar | Image credit: Luluraschi - stock.adobe.com
The Biosimilar Void: 90% of Biologics Coming Off Patent Will Lack Biosimilars

February 5th 2025

Of the 118 biologics losing exclusivity over the next decade, only 10% have biosimilars in development, meaning a vast majority of biologics have no pipeline, which limits savings potential for the health care system.

Q&A thumbnail with James D. Chambers, PhD, MPharm, MSc | Image credit Tufts Cancer Center
The Banking of Biosimilars: Insights From a Leading Health Economist

February 4th 2025

Wezlana | background image: autoinjector pen | Image credit: nazif - stock.adobe.com
Welcome Wezlana: The First Stelara Biosimilar to Launch in the US

January 31st 2025

eye on pharma banner
Eye on Pharma: Teva, Formycon, Celltrion Biosimilar Updates in Global Markets

January 26th 2025

eye on pharma banner
Eye on Pharma: Korean Drugmakers’ Impact in Europe; New Denosumab, Eculizumab Deals

January 11th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.